• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊维菌素与阿苯达唑治疗粪类圆线虫感染的比较:60例开放研究结果

Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases.

作者信息

Datry A, Hilmarsdottir I, Mayorga-Sagastume R, Lyagoubi M, Gaxotte P, Biligui S, Chodakewitz J, Neu D, Danis M, Gentilini M

机构信息

Département de Maladies Infectieuses, Tropicales et Parasitaires et de Santé Publique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

出版信息

Trans R Soc Trop Med Hyg. 1994 May-Jun;88(3):344-5. doi: 10.1016/0035-9203(94)90110-4.

DOI:10.1016/0035-9203(94)90110-4
PMID:7974685
Abstract

Ivermectin is highly effective against animal intestinal nematodes and is used in the treatment of onchocerciasis in humans. A study was undertaken to compare the efficacy of the drug with that of albendazole in the treatment of uncomplicated strongyloidiasis. Sixty patients with confirmed Strongyloides stercoralis infection were enrolled in an open randomized study and given either albendazole, 400 mg/d for 3 d or ivermectin, 150-200 micrograms/kg in a single dose. Efficacy and tolerance were evaluated on days 7, 30 and 90. Each visit included a parasitological examination of 3 stool specimens, using saline and Kato smears and formalin-ether and Baermann concentrations. Fifty-three patients were eligible for evaluation. Parasitological cure was obtained in 24 of the 29 patients treated with ivermectin (83%) and in 9 of the 24 patients who were given albendazole (38%); ivermectin was significantly more effective than albendazole (P < 0.01). Clinical and biological adverse reactions were negligible in both treatment groups. The 20 patients who failed therapy were given a second treatment course with 150-200 micrograms/kg of ivermectin in a single dose or on 2 consecutive days. Sixteen patients were cured and the other 4 had only incomplete follow-up. Ivermectin therefore constitutes an acceptable therapeutic alternative for uncomplicated strongyloidiasis.

摘要

伊维菌素对动物肠道线虫高效,可用于治疗人类盘尾丝虫病。开展了一项研究,比较该药与阿苯达唑治疗单纯性类圆线虫病的疗效。60例确诊为粪类圆线虫感染的患者纳入一项开放随机研究,给予阿苯达唑400mg/d,连用3天,或伊维菌素150 - 200μg/kg单剂量给药。在第7天、30天和90天评估疗效和耐受性。每次访视包括对3份粪便标本进行寄生虫学检查,采用生理盐水涂片、加藤涂片、福尔马林-乙醚法和贝曼氏浓集法。53例患者符合评估条件。接受伊维菌素治疗的29例患者中有24例(83%)获得寄生虫学治愈,接受阿苯达唑治疗的24例患者中有9例(38%)治愈;伊维菌素的疗效显著优于阿苯达唑(P < 0.01)。两个治疗组的临床和生物学不良反应均可忽略不计。治疗失败的20例患者接受了第二个疗程的治疗,单剂量或连续2天给予150 - 200μg/kg伊维菌素。16例患者治愈,另外4例随访不完整。因此,伊维菌素是单纯性类圆线虫病可接受的治疗选择。

相似文献

1
Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases.伊维菌素与阿苯达唑治疗粪类圆线虫感染的比较:60例开放研究结果
Trans R Soc Trop Med Hyg. 1994 May-Jun;88(3):344-5. doi: 10.1016/0035-9203(94)90110-4.
2
A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children.单剂量伊维菌素与三天阿苯达唑治疗儿童粪类圆线虫及其他土壤传播蠕虫感染的对比试验。
Am J Trop Med Hyg. 1996 Nov;55(5):477-81. doi: 10.4269/ajtmh.1996.55.477.
3
Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.伊维菌素单剂量和双剂量与 7 天高剂量阿苯达唑治疗慢性旋毛虫病的疗效和安全性。
PLoS Negl Trop Dis. 2011 May 10;5(5):e1044. doi: 10.1371/journal.pntd.0001044.
4
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.伊维菌素与阿苯达唑或噻苯达唑治疗粪类圆线虫感染的比较。
Cochrane Database Syst Rev. 2016 Jan 18;2016(1):CD007745. doi: 10.1002/14651858.CD007745.pub3.
5
Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.伊维菌素联合阿苯达唑延长疗程成功治疗播散性类圆线虫病:一例难治性类圆线虫病病例报告
Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):531-4.
6
Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.日本冲绳三种驱虫药治疗人体类圆线虫病疗效的比较研究。
Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):147-51.
7
Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis.伊维菌素单剂量兽用制剂与7日高剂量阿苯达唑治疗慢性类圆线虫病的疗效和安全性比较
Int J Antimicrob Agents. 2008 Jan;31(1):46-9. doi: 10.1016/j.ijantimicag.2007.08.014. Epub 2007 Nov 26.
8
Cure by ivermectin of a chronic, persistent, intestinal strongyloidosis.
Acta Trop. 1997 Sep 10;66(3):163-7. doi: 10.1016/s0001-706x(97)00675-x.
9
Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.泰国北部类圆线虫的患病率以及伊维菌素与阿苯达唑治疗对比
Southeast Asian J Trop Med Public Health. 2005 Mar;36(2):442-4.
10
Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study.阿苯达唑和伊维菌素用于控制阿根廷西北部粪类圆线虫和钩虫高流行地区的土源性蠕虫:一项基于社区的实用性研究。
PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0006003. doi: 10.1371/journal.pntd.0006003. eCollection 2017 Oct.

引用本文的文献

1
Determination of ivermectin in plasma and whole blood using LC-MS/MS.使用液相色谱-串联质谱法测定血浆和全血中的伊维菌素。
Wellcome Open Res. 2024 Aug 5;9:231. doi: 10.12688/wellcomeopenres.20613.2. eCollection 2024.
2
Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.阿奇霉素、阿苯达唑和伊维菌素联合用药在大规模药物治疗中的药代动力学、可行性和安全性:综述。
PLoS Negl Trop Dis. 2023 Jun 14;17(6):e0011224. doi: 10.1371/journal.pntd.0011224. eCollection 2023 Jun.
3
Larva Currens: Report of Seven Cases and Literature Review.
游走性幼虫病:7 例报告及文献复习。
Am J Trop Med Hyg. 2022 Dec 19;108(2):340-345. doi: 10.4269/ajtmh.21-0135. Print 2023 Feb 1.
4
: A Neglected but Fatal Parasite.一种被忽视却致命的寄生虫。
Trop Med Infect Dis. 2022 Oct 17;7(10):310. doi: 10.3390/tropicalmed7100310.
5
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials.伊维菌素对新冠肺炎住院患者和门诊患者无效;两项随机、双盲、安慰剂对照临床试验的结果
Front Med (Lausanne). 2022 Jun 16;9:919708. doi: 10.3389/fmed.2022.919708. eCollection 2022.
6
Strongyloides stercoralis.粪类圆线虫
Lung. 2022 Apr;200(2):141-148. doi: 10.1007/s00408-022-00528-z. Epub 2022 Apr 9.
7
Prevalence and risk factors of strongyloidiasis among schoolchildren in Sabach Sanjal and Upper Badibou districts in the North Bank East Region of The Gambia.冈比亚北岸东区萨巴赫·桑贾尔和上巴迪布地区学童类圆线虫病的患病率及危险因素
Parasite Epidemiol Control. 2021 Oct 21;15:e00228. doi: 10.1016/j.parepi.2021.e00228. eCollection 2021 Nov.
8
Strongyloidiasis in Children Outside the Tropics: Do We Need to Increase Awareness?非热带地区儿童的类圆线虫病:我们是否需要提高认识?
Microorganisms. 2021 Sep 8;9(9):1905. doi: 10.3390/microorganisms9091905.
9
Descriptive Investigation of Strongyloidiasis Infection and Characterization of Using Morphological and Molecular-Based Methods.使用形态学和分子生物学方法对类圆线虫病感染进行描述性调查及特征分析
Case Rep Infect Dis. 2020 Aug 20;2020:5431491. doi: 10.1155/2020/5431491. eCollection 2020.
10
Human strongyloidiasis: identifying knowledge gaps, with emphasis on environmental control.人类类圆线虫病:识别知识空白,重点关注环境控制。
Res Rep Trop Med. 2014 Aug 20;5:55-63. doi: 10.2147/RRTM.S63138. eCollection 2014.